Insights of different analytical approaches for estimation of budesonide as COVID-19 replication inhibitor in its novel combinations: green assessment with AGREE and GAPI approaches.

Hammouda, Mohammed E A; El-Masry, Amal A; El-Ashry, Saadia M; El-Wasseef, Dalia R

Hammouda, Mohammed E A; El-Masry, Amal A; El-Ashry, Saadia M; El-Wasseef, Dalia R.

Afiliación

Hammouda MEA; Department of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt. drmedo4u@mans.edu.eg.
El-Masry AA; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Horus University - Egypt, New Damietta, Egypt. drmedo4u@mans.edu.eg.
El-Ashry SM; Department of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt.
El-Wasseef DR; Department of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt.

BMC Chem ; 17(1): 17, 2023 Mar 14.

Article en En | MEDLINE | ID: mdl-36918985

Palabras clave

AGREE; Allergic rhinitis; Azelastine; Budesonide; COVID-19; First derivative; GAPI; HPLC; Inhalation corticosteroids; Ratio first derivative; Zero order

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: BMC Chem Año: 2023 Tipo del documento: Article País de afiliación: Egipto Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google